Transmission electron micrograph of pathogenic norovirus fragments
BSIP SA/Alay
A world class international the trial A norovirus mRNA vaccine is being launched with the goal of reducing the health burden caused by the nasty “winter vomiting” bug. The trial has been complicated by the emergence of a new strain of norovirus that is causing higher numbers of cases in some parts of the world, including England.
“Unfortunately, one of the most prevalent strains is not in that jab,” says Patrick Moore of the UK’s National Institute for Health and Care Research, who heads the UK branch of the trial. “Probably high cases…
